ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$ROIV:NASDAQ · ROIVANT SCIENCES LTD

Sector: health

Conviction from: NASDAQ

52-week range: 19.9642.50

Roivant Sciences is a biopharmaceutical holding company that develops and commercializes medicines and health technologies through a network of subsidiary 'vant' companies.

4 tracked filer(s) hold this · 1 opened, 1 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 56 — mean of 4 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Ancora42New buy25$9140.0%
Steve Cohen / Point7275Added +7%4,827,277$176,533,5200.2%
David Einhorn / Greenlight45Trimmed -47%1,131,747$41,387,9881.2%
Paul Tudor Jones / Tudor61Trimmed -45%52,200$1,908,9540.0%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.